🔎 Trials Near Me

Home › High Blood Pressure › South Carolina

High Blood Pressure clinical trials in South Carolina

14 studies for High Blood Pressure are looking for participants at sites in South Carolina.

Cities in South Carolina

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Piedmont Research Partners, LLC, Fort Mill
  • Velocity Clinical Research-Gaffney-69046, Gaffney
  • Tribe Clinical Research LLC - Greenville, Greenville
  • and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07064473

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Monroe Biomedical Research - Charleston, North Charleston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07783802

Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

  • OnSite Clinical Solutions, LLC, Fort Mill
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07511361

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Care Access - Mauldin, Mauldin
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07794579

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Charleston
  • Research Site, Columbia
  • Research Site, Orangeburg
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06742723

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

  • MUSC, Mt. Pleasant
Recruiting
Ages 22 to 75 · All sexes · Updated Sep 24, 2026 · NCT06559891

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  • Medical University of South Carolina, Charleston
Recruiting
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06059638

Improving the Collaborative Health of Adult Dyads

  • University of South Carolina, Columbia
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05370014

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Columbia
  • Clinical Trial Site, Greenville
  • Clinical Trial Site, Greer
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

  • Retension Clinical Site, Charleston
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 10, 2026 · NCT07142356

Global Paradise System US Post Approval Study

  • Medical University of South Carolina, Charleston
  • Prisma Health Richland Hospital, Columbia
  • Spartanburg Regional Medical Center, Spartanburg
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06297291

A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

  • Walker Family Care, Little River
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT07610278

Community Health Worker Coaching to Reduce Cardiovascular Risk Among Women After a Hypertensive Disorder of Pregnancy

  • University of South Carolina, Columbia
Recruiting
Ages 18 and older · Women · Updated May 4, 2026 · NCT07457970

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

  • Vanda Investigative Site, Charleston
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Feb 27, 2026 · NCT07090161

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.